A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.21313 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Cansu Akkan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, School of Medicine, Canakkale Onsekiz Mart University. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, Renin, Lung. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The potential role of the renin-angiotensin-aldosterone system (RAAS) in the pathogenesis of coronavirus disease 2019 (COVID-19) is controversial, with concerns mainly about the part RAAS peptides play in the prediction of progression to more severe disease. Given the importance of COVID-19 prognostication at early disease stages, we established and validated a multivariable risk stratification tool for COVID-19 associated lung involvement by utilizing a combination of RAAS peptides. Methodology: In this prospective study, circulating renin and angiotensin converting enzyme-2 (ACE-2) levels were measured in 116 COVID-19 patients who were admitted to our hospital from March 30, 2021 to January 24, 2022 and underwent a lung computed tomography (CT) scan. Clinical severity was measured with a national early warning score (NEWS). Associations among RAAS peptides, inflammation-dependent biomarkers, demographic variables, and clinical outcomes were studied using logistic regression and Cox proportional-hazards models.
Results
We assessed 116 COVID-19 patients (mean age 45.1 ± 12.6 years; 51.7% male), of whom 66 (56.9%) had COVID-19 associated pneumonia. Baseline circulating ACE-2 (2.63 ± 0.12 ng/mL) and renin levels (85.04 ± 6.8 ng/L) were lower in patients with COVID-19 related pneumonia compared to patients without pneumonia (6.4 ± 0.7 ng/mL and 211.6 ± 21.9 ng/L, respectively) (p < 0.001 for both). Both RAAS components were found to be significantly related to adverse outcomes, including COVID-19 associated pneumonia and intensive care unit (ICU) admission, in both crude and adjusted multivariable logistic regression analyses.
Conclusions
Circulating ACE-2 and renin levels can predict lung involvement in COVID-19 patients, and they display good correlation and agreement with NEWS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, School of Medicine, Canakkale Onsekiz Mart University.
- Department of Biochemistry, School of Medicine, Canakkale Onsekiz Mart University.
- Department of Internal Medicine, School of Medicine, Canakkale Onsekiz Mart University.
Zitieren
APA
Akkan, C., Daş, M., Bardakci, O., Şehitoğlu, M. H., Akdur, G., Akman, C., Akdur, O., & Beyazit, Y. (2025). A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21313
Vancouver
Akkan C, Daş M, Bardakci O, Şehitoğlu MH, Akdur G, Akman C, et al. A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.21313
BibTeX
@article{Akkan2025,
author = {Akkan, Cansu and Daş, Murat and Bardakci, Okan and Şehitoğlu, Müşerref Hilal and Akdur, Gökhan and Akman, Canan and Akdur, Okhan and Beyazit, Yavuz},
title = {A prediction model for lung involvement using circulating angiotensin converting enzyme-2 and renin levels in COVID-19 patients},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.21313}
}
EUVIMED